Contemporary Multimodal Management of Cutaneous Malignancies: Surgery, Radiotherapy, Systemic Therapy, Molecular Targeting and Immunotherapy
Overall, treatment selection is increasingly determined by tumour type, stage, resectability and validated biomarkers, while several important questions concerning optimal sequencing, long-term outcomes and under-represented patient groups remain unresolved.